EODData

MEMBERSHIP REGISTER LOG IN

NYSE, QGEN:

29 Aug 2025
LAST:

46.50

CHANGE:
 0.36		OPEN:
46.11		HIGH:
46.63		ASK:
0.00		VOLUME:
1.95M
CHG(%):
0.78		PREV:
46.14		LOW:
46.08		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Aug 2546.1146.6346.0846.501.95M
28 Aug 2546.5846.8045.8146.145.36M
27 Aug 2548.7248.7347.7847.99796.4K
26 Aug 2549.2549.2848.7848.861.25M
25 Aug 2549.8949.9348.6848.90621.8K
22 Aug 2549.1149.9649.1049.74882.8K
21 Aug 2549.3349.4949.1149.13695.5K
20 Aug 2549.2249.5049.0449.201.14M
19 Aug 2548.7549.3548.6849.191.18M
18 Aug 2549.3149.4348.6248.651.45M

COMPANY PROFILE

Name:
About:Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Sector:Healthcare
Address:Hulsterweg 82, Venlo, Netherlands, 5912 PL
Website:https://www.qiagen.com
CUSIP:N72482123
CIK:0001015820
ISIN:NL0015002CX3
FIGI:BBG000GTYWL7

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:29.09
DivYield:0.01
Div/Share:0.25
PtB:3.08
PtS:5.29
EBITDA:997.76M
Shares:216.83M
Market Cap:10.083B

TECHNICAL INDICATORS

MA5:47.68
MA10:48.43
MA20:48.65
MA50:48.67
MA100:46.08
MA200:44.18
STO9:9.42
STO14:9.42
RSI14:40.28
WPR14:-90.00
MTM14:-2.47
ROC14:-0.05
ATR:0.80
Week High:49.96
Week Low:45.81
Month High:51.39
Month Low:45.81
Year High:51.88
Year Low:37.63
Volatility:5.63

RECENT DIVIDENDS

Date Amount
02 Jul 2025$0.25
29 Jan 2025$1.26
30 Jan 2024$1.36
25 Jan 2017$1.15
27 Dec 2002$0.03
26 Dec 2002$0.00